Hatchery Disinfection Policy and Procedures
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Phenol Health and Safety Guide
C - z_ IPCS INTERNATIONAL._ PROGRAMME ON CHEMICAL SAFETY OD 341 Health and Safety Guide No. 88 .P5 94 Ph c.2 PHENOL HEALTH AND SAFETY GUIDE ' UNITED NATIONS INTERNATIONAL ENVffiONMENTPROG~E LABOUR ORGANISATION WORLD HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION, GENEVA 1994 1 I) 1\ ' ~Ii>cs Other HEALTH AND SAFETY GUIDES available: (continued on inside back cover) Acrolein (No . 67, 1992) Endrin (No. 60, 1991) Acrylamide (No. 45 , 1991) Epichlorohydrin (No. 8, 1987) Acrylonitrile (No. I, 1986) Ethylene oxide (No. 16, 1988) Aldicarb (No. 64, 1991) Fenitrothion (No. 65, 1991) Aldrin and dieldrin (No. 21 , 1988) Fenvalerate (No. 34, 1989) Allethrins (No. 24, 1989) Folpet (No. 72, 1992) Amitrole (No. 85 , 1994) Formaldehyde (No. 57, 1991) Ammonia (No. 37, 1990) Heptachlor (No. 14, 1988) Arsenic compounds, inorganic, other than Hexachlorobutadiene (No. 84, 1993) arsine (No. 70, 1992) Hexachlorocyclohexanes, alpha- and Atrazine (No. 47, 1990) beta- (No. 53, 1991) Barium (No. 46 , 1991) Hexachlorocyclopentadiene (No. 63 , 1991) Benomyl (No. 81, 1993) n-Hexane (No. 59, 1991) Bentazone (No. 48, 1990) Hydrazine (No. 56, 1991) Beryllium (No. 44, 1990) Isobenzan (No. 61 , 1991) !-Butanol (No. 3, 1987) Isobutanol (No. 9, 1987) 2-Butanol (No. 4, 1987) Kelevan (No. 2, 1987) ten-Butanol (No. 7, 1987) Lindane (No. 54 , 1991) Camphechlor (No. 40, 1990) Magnetic fields (No. 27, 1990) Captafol (No. 49, 1990) Methamidophos (No. 79, 1993) Captan (No. 50, 1990) Methyl bromide (Bromomethane) (No. 86, 1994) Carbaryl (No. 78, 1993) Methyl isobutyl ketone (No. 58, 1991) Carbendazim (No. 82, 1993) Methyl parathion (No. 75, 1992) Chlordane (No. 13 , 1988) Methylene chloride (No. -
Chemical Matricectomy with Phenol Versus Aesthetic Reconstruction. a Single Blinded Randomized Clinical Trial
Journal of Clinical Medicine Article The Treatment of Ingrown Nail: Chemical Matricectomy With Phenol Versus Aesthetic Reconstruction. A Single Blinded Randomized Clinical Trial Juan Manuel Muriel-Sánchez 1, Ricardo Becerro-de-Bengoa-Vallejo 2 , Pedro Montaño-Jiménez 1 and Manuel Coheña-Jiménez 1,* 1 Facultad de Enfermería, Fisioterapia y Podología, Universidad de Sevilla, 41009 Sevilla, Spain; [email protected] (J.M.M.-S.); [email protected] (P.M.-J.) 2 Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Received: 29 January 2020; Accepted: 18 March 2020; Published: 20 March 2020 Abstract: Background: In onychocryptosis surgery, incisional and non-incisional matricectomy is indicated according to the stage. The chemical matricectomy with 88% phenol solution is the gold standard and a wedge resection is indicated for more advanced stages. The aesthetic reconstruction has the advantages of the incisional procedure without eponychium incisions and an effectiveness similar to the chemical matricectomy with phenol. Objective: To compare the recurrence and the healing time between the chemical matricectomy with phenol and the aesthetic reconstruction. Methods: A comparative, prospective, parallel, randomized, and one-blinded clinical trial was registered with the European Clinical Trials Database (EudraCT) with identification number 2019-001294-80. Thrity-four patients (56 feet) with 112 onychocryptosis were randomized in two groups. Thirty-six were treated with chemical matricectomy with phenol and 76 with aesthetic reconstruction. Each patient was blind to the surgical procedure assigned by the investigator. The primary outcome measurements were healing time and recurrence. The secondary outcome measurements were post-surgical bleeding, pain, inflammation, and infection rate. -
European Contact Lens Society of Ophthalmologists ECLSO
European Contact Lens Society of Ophthalmologists ECLSO Course de Base en Contactologie I – IV Basiskurs in Kontaktologie I - IV Dr. med. Albert Franceschetti, Genève Michael Bärtschi, M.Sc.Optom. et M.Med.Educ.,Bern Optics and Contact Lenses What should I know about optics and physiological optics when I fit contact lenses ? Visual acuity = 1.0 • US notation 20/20 (20 feet) • Metric notation 6/6 (6 meters) • Decimal 10/10 (Monoyer) • Logarythmic Distance spectacles-eye • The position of the contact lens is different in relation to the eye. This is obviously the first criterion to take into consideration. • According to the power of the spectacles, the difference ǻ between the power of spectacle lenses and the contact lenses will be more or less important. Formula • DL power of the glasses (supposed perfect DL correction) DCL = -------------- 1 – d D • DCL power of the contact L lens (lens + tear meniscus) • d distance between the lens and the contact lens • ǻ difference between the power DCL and DL ǻ • ǻ = DCL –DL is always positive • ǻ = DCL –DL increases if the distance eye- glasses increases • The value d can be superior to 12mm if one uses trial lenses or refractor. Variation of powers between the two systems (contact lenses and spectacle) Distance eye- DL -20 -15 -10 -8 -5 +4 +10 glasses -16.13 -12.71 -8.93 -7.30 -4.72 +4.20 +11.36 DCL d=12m 3.87 2.29 1.07 0.70 0.28 0.20 1.36 m ǻ -15.38 -12.24 -8.70 -7.14 -4.65 +4.26 +11.76 DCL D=15 ǻ 4.62 2.76 1.30 0.86 0.35 0.26 1.76 mm Magnification • The distance eye-spectacles versus eye contact lens being different, the magnification of the retinal image will be different. -
Partial Nail Avulsion and Chemical Matricectomy: Ingrown Toenails
Partial nail avulsion and chemical matricectomy: Ingrown toenails Intervention Removal (avulsion) of an ingrowing section of toenail and application of a caustic chemical to destroy the nail matrix (matricectomy). Indication Partial nail avulsion and chemical matricectomy relieve symptoms and prevent regrowth of the nail edge or recurrence of the ingrowing toenail. Possible causes of ingrowing toenails include improper Ingrowing toenails are a common problem and occur when the edge of the nail grows trimming of the nail, tearing nail into flesh at the side of the nail, causing a painful injury. The punctured skin can become off, overly curved nail, certain inflamed and infected. Ingrown toenails can be classified into three stages (see Figure 1): activities (eg running) and • mild (or Stage I) wearing constricting footwear. – oedema, erythema and pain • moderate (or Stage II) – inflammation and inflection with or without purulent discharge, in addition to the symptoms of Stage I • severe (or Stage III) – chronic inflammation, epithelialised hypertrophic granulation tissue. Figure 1. Three stages of ingrown toenails Source: Eekhof JA, Van Wijk B, Knuistingh Neven A, van der Wouden JC. Interventions for ingrowing toenails. The Cochrane Database of Systematic Reviews 2012;4:CD001541. Surgical interventions are commonly performed for patients in Stages II and III, and are more effective than non-surgical interventions in preventing the recurrence of an ingrowing toenail. The addition of chemical cauterisation (most commonly with phenol) at Stages II and III, may be more effective in preventing recurrence and regrowth of the ingrowing toenail than surgery alone. Contraindications Diminished vascular supply to the digit is a relative contraindication to nail surgery. -
Phenol Red Solution, 1.0% Alcoholic MSDS # 523.00
Material Safety Data Sheet Page 1 of 2 Phenol Red Solution, 1.0% Alcoholic MSDS # 523.00 Section 1: Product and Company Identification Phenol Red Solution, 1.0% Alcoholic Synonyms/General Names: N/A Product Use: For educational use only Manufacturer: Columbus Chemical Industries, Inc., Columbus, WI 53925. 24 Hour Emergency Information Telephone Numbers CHEMTREC (USA): 800-424-9300 CANUTEC (Canada): 613-424-6666 ScholAR Chemistry; 5100 W. Henrietta Rd, Rochester, NY 14586; (866) 260-0501; www.Scholarchemistry.com Section 2: Hazards Identification Red to orange color liquid, mild odor. HMIS (0 to 4) Health 1 WARNING! Alcohol based solution, flammable liquid and moderately toxic by ingestion. Fire Hazard 3 Flammable liquid, keep away from all ignition sources. Reactivity 0 Target organs: Central nervous system, liver, kidneys. This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Section 3: Composition / Information on Ingredients Phenol Red, sodium salt (3447-61-1), 1%. Isopropyl Alcohol (67-63-0), 49.5%. Water (7732-18-5), 49.5%. Section 4: First Aid Measures Always seek professional medical attention after first aid measures are provided. Eyes: Immediately flush eyes with excess water for 15 minutes, lifting lower and upper eyelids occasionally. Skin: Immediately flush skin with excess water for 15 minutes while removing contaminated clothing. Ingestion: Call Poison Control immediately. Aspiration hazard. Rinse mouth with cold water. Give victim 1-2 tbsp of activated charcoal mixed with 8 oz water. Inhalation: Remove to fresh air. If not breathing, give artificial respiration. Section 5: Fire Fighting Measures Class IB Flammable Liquid. -
U.S. EPA, Pesticide Product Label, 776 DISINFECTANT VIRUCIDE
, 1-ls-lf9 UNITED ST ATES ENVIRONMENTAL PROTECTION AGENCY Carroll Company 2900 West Kingsley Road Garland, TX 75041 Subject: 776 Disinfectant, Virucide and Cleaner EPA Registration No. 4313-22 Amendment Dated November 9, 1998 Attn: Linda Kirk Kirby Director, Regulatory Compliance The amendment referred to above, submitted in connection with registration under the Federal Insecticide, Fungicide and Rodenticide Act, as amended, is acceptable. A stamped copy of the label is enclosed for your records. Submit one (I) copy ofthe finished printed label before this product is released for shipment. If you have any questions concerning the comments in this letter, you should contact Zenobia Jones at (703) 308-6198. Sincerely, ) JJ~lvJHdL Velma Noble Product Manager 31 Regulatory Management Branch I Antimicrobial Division (751 OW) COHCURRI!HCI!S ::::} ·m·I~ .Q........ ................ - ....................................... -................................ _............................. DATE ) . \-1i.-9l1... ....... ................... ................. .................................................................................... OFFICIAL FILE COpy Primed Oft R~cye/~d Paper ~' '....,-. " DISINFECTANT, UIRUCIDE* AND CLEANER FOR HOSPITAL INSTITUTIONAL ACTIVE INGREDIENT: AND iNDUSTRIAL USE Alkyl (C14 50%, C12 40%, C16 10%) dimelhyl • benzyl ammonium chloride........... 3.3 Yo ·Hum8n immunodeficiency virus, Type 1 (HIV-l) INERT INGR~DIENTS .................. 96.7% KEEP OUT OF REACH OF CHILDREN DANGER See back panel for additional precautionary -
Chemical Disinfectants | Disinfection & Sterilization Guidelines | Guidelines Library | Infection Control | CDC 3/19/20, 14:52
Chemical Disinfectants | Disinfection & Sterilization Guidelines | Guidelines Library | Infection Control | CDC 3/19/20, 14:52 Infection Control Chemical Disinfectants Guideline for Disinfection and Sterilization in Healthcare Facilities (2008) Alcohol Overview. In the healthcare setting, “alcohol” refers to two water-soluble chemical compounds—ethyl alcohol and isopropyl alcohol —that have generally underrated germicidal characteristics 482. FDA has not cleared any liquid chemical sterilant or high- level disinfectant with alcohol as the main active ingredient. These alcohols are rapidly bactericidal rather than bacteriostatic against vegetative forms of bacteria; they also are tuberculocidal, fungicidal, and virucidal but do not destroy bacterial spores. Their cidal activity drops sharply when diluted below 50% concentration, and the optimum bactericidal concentration is 60%–90% solutions in water (volume/volume) 483, 484. Mode of Action. The most feasible explanation for the antimicrobial action of alcohol is denaturation of proteins. This mechanism is supported by the observation that absolute ethyl alcohol, a dehydrating agent, is less bactericidal than mixtures of alcohol and water because proteins are denatured more quickly in the presence of water 484, 485. Protein denaturation also is consistent with observations that alcohol destroys the dehydrogenases of Escherichia coli 486, and that ethyl alcohol increases the lag phase of Enterobacter aerogenes 487 and that the lag phase e!ect could be reversed by adding certain amino acids. The bacteriostatic action was believed caused by inhibition of the production of metabolites essential for rapid cell division. Microbicidal Activity. Methyl alcohol (methanol) has the weakest bactericidal action of the alcohols and thus seldom is used in healthcare 488. The bactericidal activity of various concentrations of ethyl alcohol (ethanol) was examined against a variety of microorganisms in exposure periods ranging from 10 seconds to 1 hour 483. -
Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008
Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 William A. Rutala, Ph.D., M.P.H.1,2, David J. Weber, M.D., M.P.H.1,2, and the Healthcare Infection Control Practices Advisory Committee (HICPAC)3 1Hospital Epidemiology University of North Carolina Health Care System Chapel Hill, NC 27514 2Division of Infectious Diseases University of North Carolina School of Medicine Chapel Hill, NC 27599-7030 1 Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 3HICPAC Members Robert A. Weinstein, MD (Chair) Cook County Hospital Chicago, IL Jane D. Siegel, MD (Co-Chair) University of Texas Southwestern Medical Center Dallas, TX Michele L. Pearson, MD (Executive Secretary) Centers for Disease Control and Prevention Atlanta, GA Raymond Y.W. Chinn, MD Sharp Memorial Hospital San Diego, CA Alfred DeMaria, Jr, MD Massachusetts Department of Public Health Jamaica Plain, MA James T. Lee, MD, PhD University of Minnesota Minneapolis, MN William A. Rutala, PhD, MPH University of North Carolina Health Care System Chapel Hill, NC William E. Scheckler, MD University of Wisconsin Madison, WI Beth H. Stover, RN Kosair Children’s Hospital Louisville, KY Marjorie A. Underwood, RN, BSN CIC Mt. Diablo Medical Center Concord, CA This guideline discusses use of products by healthcare personnel in healthcare settings such as hospitals, ambulatory care and home care; the recommendations are not intended for consumer use of the products discussed. 2 -
Compatible Cleaning Solutions Chart*
Compatible Cleaning Solutions Chart* Reactive Chemicals Natural Rubber Polyurethane 316 Stainless Vinyl Nitrile FKM (Viton) Aluminum Neoprene Hypalon Silicone UHMW Hytrel Nitrile / SBR EPDM Nylon Brass XLPE Steel PTFE CPE Fluid PVC Notes: Alcohols +++++++–+–+– +++++ • Ingredient in Some (Methanol & Ethanol) Anti-Viral Cleansers Bleaching and Cleaning Bleach Solution + + • ••––– • + • – + • • – – – + – – Agent; Sodium (Sodium Hypochlorite) Hypochlorite Butyl Alcohol + + • + + + + + + + – + + + + + + + + + Potent virucidal agent Chlorine – – – – – – + + – – • • • Antiseptic; Anti-Viral – + + + + + ••– • + + • + + + + • + – – Insecticides and Citric Acid disinfectants; Antiviral Copper Chloride – + + + ••+++++++++++ +–– Copper Chloride Ethyl Alcohol + + + + + + + + • + • + + + + + + • + + + • + Ingredient in Some (Ethanol) Anti-Viral Cleansers Toilet, Tile and Porcelain Hydrochloric Acid +++–––––++–+++–––––– Cleaner; Anti-Viral (Polio) Hydrogen Peroxide + • – – – – – + • + – + • • – + • • ••–– Multipurpose Cleaner +++ –++–+––+ • ••–––– Antiseptic; Antiviral Iodine (Polio) + + + + ••+++–++++++++++++ Ingredient in Some Isopropyl Alcohol Anti-Viral Cleansers Phenol + • – – – – – – + – – + + + – – + + • + ••– Anti-Virus (Rhinovirus) (Carbolic Acid) (Adenovirus) Sodium Chloride ++++++++++++++++ • + – • Anti-Virus Sodium Hypochlorite ••+++––––++– • + + – – – ••–– Bleaching and Cleaning Agent (Bleach) Quaternary Ammonium + + + + + + + Common Anti-Viral; Salts (Lysol) Benzalkonium Chloride (Lysol) Lactic Acid – + • + – + + • + • • + + – + + + – -
US EPA, Pesticide Product Label, XHC-IA,06/07/2018
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, DC 20460 OFFICE OF CHEMICAL SAFETY AND POLLUTION PREVENTION June 7, 2018 Bridget Middleton, M.S. Regulatory Specialist Ecolab Inc. 1 Ecolab Place St. Paul, MN 55102 Subject: PRIA Label Amendment – Adding Efficacy Claims and Emerging Viral Pathogens Language Product Name: XHC-IA EPA Registration Number: 1677-249 Application Date: January 16, 2018 Decision Number: 537595 Dear Ms. Middleton: The amended label referred to above, submitted in connection with registration under the Federal Insecticide, Fungicide and Rodenticide Act, as amended, is acceptable. This approval does not affect any conditions that were previously imposed on this registration. You continue to be subject to existing conditions on your registration and any deadlines connected with them. A stamped copy of your labeling is enclosed for your records. This labeling supersedes all previously accepted labeling. You must submit one copy of the final printed labeling before you release the product for shipment with the new labeling. In accordance with 40 CFR 152.130(c), you may distribute or sell this product under the previously approved labeling for 18 months from the date of this letter. After 18 months, you may only distribute or sell this product if it bears this new revised labeling or subsequently approved labeling. “To distribute or sell” is defined under FIFRA section 2(gg) and its implementing regulation at 40 CFR 152.3. Because you have opted to add statements pertaining to emerging viral pathogens to your label as described in the August 19, 2016, Guidance to Registrants: Process For Making Claims Against Emerging Viral Pathogens Not On EPA-Registered Disinfectant Labels (“Guidance”), https://www.epa.gov/sites/production/files/2016- 09/documents/emerging_viral_pathogen_program_guidance_final_8_19_16_001_0.pdf, you are subject to the following additional terms of registration: 1. -
Components of a Vaccine
Components of a vaccine Vaccines include a variety of ingredients including antigens, stabilizers, adjuvants, antibiotics, and preservatives. They may also contain residual by-products from the production process. Knowing precisely what is in each vaccine can be helpful when investigating adverse events following immunization (AEFIs) and for choosing alternative products for those who have allergies or have had an adverse event known or suspected to be related to a vaccine component. Antigens Antigens are the components derived from the structure of disease-causing organisms, which are recognized as 'foreign' by the immune system and trigger a protective immune response to the vaccine. You have already learned about antigens. Click here if you want to review the chapter on antigens. Stabilizers Stabilizers are used to help the vaccine maintain its effectiveness during storage. Vaccine stability is essential, particularly where the cold chain is unreliable. Instability can cause loss of antigenicity and decreased infectivity of LAV. Factors affecting stability are temperature and acidity or alkalinity of the vaccine (pH). Bacterial vaccines can become unstable due to hydrolysis and aggregation of protein and carbohydrate molecules. Stabilizing agents include MgCl2 (for OPV), MgSO4 (for measles), lactose- sorbitol and sorbitol-gelatine. Adjuvants Adjuvants are added to vaccines to stimulate the production of antibodies against the vaccine to make it more effective. Aluminium salts example Adjuvants have been used for decades to improve the immune response to vaccine antigens, most often in inactivated (killed) vaccines. In conventional vaccines, adding adjuvants into vaccine formulations is aimed at enhancing, accelerating and prolonging the specific immune response to vaccine antigens. -
A New Disinfectant
J Clin Pathol: first published as 10.1136/jcp.19.4.318 on 1 July 1966. Downloaded from J. clin. Path. (1966), 19, 318 A new disinfectant PHILIP W. ROSS From the Department of Bacteriology, University of Edinburgh SYNOPSIS Qualitative and quantitative tests have been carried out to assess the value of Cidexl, a glutaraldehyde solution, as a disinfectant. Most of the tests were qualitative and were carried out in conditions as closely resembling those found in hospital practice as possible. Recently used anaesthetic equipment, catheters, and a cysto- scope, which had been artificially contaminated with suspensions of Staph. aureus, Ps. pyocyanea, and Esch. coli, were used in the tests. The results show Cidex to be a useful disinfectant with a valuable potential in disinfecting hospital articles which, due to their perishable nature or the fragility of component parts, cannot be treated by physical means. This paper presents results of several tests done on The present test is simple, easily reproducible, uses Cidex, an activated glutaraldehyde solution, to pathogens commonly associated with hospital cross- assess its effectiveness as a disinfecting agent. Pre- infection, and includes testing the effect of organic matter vious work by Pepper and Chandler (1963) has on the system. shown it to have a sporicidal effect and Borick, MATERIALS Dondershine, and Chandler (1964) have published details of work done on its viricidal properties. The pathogens Ps. pyocyanea, Esch. coli, and Staph. not been examined in the aureus, phage type 80/81, were used. These aspects have http://jcp.bmj.com/ present study. The purpose here is to assess the A cystoscope and four Jaques catheters were tested ability of this agent to kill organisms which cause after being artificially contaminated, and an anaesthetic in hospital cross-infection, notably mask, 31 in.